SEARCH

SEARCH BY CITATION

References

  • Chamberlain NL, Driver ED, Miesfeld RL. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res. 1994;22: 31813186.
  • Edwards SM, Badzioch MD, Minter R., Hamoudi R., Collins N., Ardern-Jones A., Dowe A., Osborne S., Kelly J., Shearer R., Easton DF, Saunders GF, Dearnaley DP, Eeles RA. Androgen receptor polymorphisms: association with prostate cancer risk, relapse and overall survival. Int J Cancer. 1999;84: 458465.
  • Faber PW, Kuiper GGJM, van Rooij HCJ, van der Korput J., Brinkmann AO, Trapman J.. The N-terminal domain of the human androgen receptor is encoded by one, large exon. Mol Cell Endocrinol. 1989;61: 257262.
  • Ferlin A., Bartoloni L., Rizzo G., Roverato A., Garolla A., Foresta C.. Androgen receptor gene CAG and GGC repeat lengths in idiopathic male infertility. Mol Hum Reprod. 2004;10: 417421.
  • Gao T., Marcelli M., McPhaul MJ. Transcriptional activation and transient expression of the human androgen receptor. J Steroid Biochem Mol Biol. 1996;59: 920.
  • Giovannucci E., Stampfer MJ, Krithivas K., Brown M., Dahl D., Brufsky A., Talcott J., Hennekens CH, Kantoff PW. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci U S A. 1997;94: 33203323.
  • Hakimi JM, Schoenberg MP, Rondinelli RH, Piantadosi S., Barrack ER. Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer. Clin Cancer Res. 1997;3: 15991608.
  • Heinlein CA, Chang C.. Androgen receptor in prostate cancer. Endocr Rev. 2004;25: 276308.
  • Hickey T., Chandy A., Norman RJ. The androgen receptor CAG repeat polymorphism and X-chromosome inactivation in Australian Caucasian women with infertility related to polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87: 161165.
  • Hsing AW, Gao YT, Wu G., Wang X., Deng J., Chen YL, Sesterhenn IA, Mostofi FK, Benichou J., Chang C.. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China. Cancer Res. 2000;60: 51115116.
  • Kazemi-Esfarjani P., Trifiro MA, Pinsky L.. Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies. Hum Mol Genet. 1995;4: 523527.
  • La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991;352: 7779.
  • Lubahn DB, Joseph DR, Sar M., Tan J., Higgs HN, Larson RE, French FS, Wilson EM. The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Mol Endocrinol. 1988a;2: 12651275.
  • Lubahn DB, Joseph DR, Sullivan PM, Willard HF, French FS, Wilson EM. Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science. 1988b;240: 327330.
  • Lundin KB, Giwercman A., Richthoff J., Abrahamsson PA, Giwercman YL. No association between mutations in the human androgen receptor GGN repeat and inter-sex conditions. Mol Hum Reprod. 2003;9: 375379.
  • Mishra D., Thangaraj K., Mandhani A., Kumar A., Mittal R.. Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population? Clin Genet. 2005;68: 5560.
  • Ruhayel Y., Lundin K., Giwercman Y., Hallden C., Willen M., Giwercman A.. Androgen receptor gene GGN and CAG polymorphisms among severely oligozoospermic and azoospermic Swedish men. Hum Reprod. 2004;19: 20762083.
  • Sasaki M., Sakuragi N., Dahiya R.. The CAG repeats in exon 1 of the androgen receptor gene are significantly longer in endometrial cancer patients. Biochem Biophys Res Commun. 2003;305: 11051108.
  • Singh R., Deepa SR, Madhavi S., Gupta NJ, Chakravarty B., Singh L., Thangaraj K.. Male infertility: no evidence of involvement of androgen receptor gene among Indian men. J Androl. 2006;27: 102105.
  • Stanford JL, Just JJ, Gibbs M., Wicklund KG, Neal CL, Blumenstein BA, Ostrander EA. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res. 1997;57: 11941198.
  • Tayeb MT, Clark C., Murray GI, Sharp L., Haites NE, McLeod HL. Length and somatic mosaicism of CAG and GGN repeats in the androgen receptor gene and the risk of prostate cancer in men with benign prostatic hyperplasia. Ann Saudi Med. 2004;24: 2126.
  • Tesarik J., Guido M., Mendoza C., Greco E.. Human spermatogenesis in vitro: respective effects of follicle-stimulating hormone and testosterone on meiosis, spermiogenesis, and Sertoli cell apoptosis. J Clin Endocrinol Metab. 1998;83: 44674473.
  • Thangaraj K., Gupta NJ, Pavani K., Reddy AG, Subramainan S., Rani DS, Ghosh B., Chakravarty B., Singh L.. Y chromosome deletions in azoospermic men in India. J Androl. 2003;24: 588597.
  • Thangaraj K., Joshi MB, Reddy AG, Gupta NJ, Chakravarty B., Singh L.. CAG repeat expansion in the androgen receptor gene is not associated with male infertility in Indian populations. J Androl. 2002;23: 815818.
  • Tut TG, Ghadessy FJ, Trifiro MA, Pinsky L., Yong EL. Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. J Clin Endocrinol Metab. 1997;82: 37773782.
  • Yong EL, Ghadessy F., Wang Q., Mifsud A., Ng SC. Androgen receptor transactivation domain and control of spermatogenesis. Rev Reprod. 1998;3: 141144.
  • Yong EL, Loy CJ, Sim KS. Androgen receptor gene and male infertility. Hum Reprod Update. 2003;9: 17.